Integrated PTSD and Chronic Pain Treatment
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT07225049
- Status
- Recruiting
Conditions
- Chronic Pain
- PTSD
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Integrated Treatment for PTSD and Chronic Pain — BEHAVIORALThe intervention consists of 12 90-minute virtual psychotherapy sessions scheduled twice per week. The treatment integrates modules from Prolonged Exposure and Cognitive Behavioral Therapy for Chronic Pain.
Study Details
Posttraumatic stress disorder (PTSD) occurs in approximately 7% of adults in the general population. PTSD greatly impacts quality of life and often co-occurs with other conditions such as chronic pain. Individuals with co-morbid PTSD and chronic pain demonstrate higher PTSD symptoms and pain (as well as greater anxiety, depression, disability, and opioid use) compared to those with only one of those conditions. Gold standard treatments exist for both PTSD (e.g., Prolonged Exposure; PE) and chronic pain (e.g., Cognitive Behavioral Therapy for Chronic Pain; CBT-CP) and are generally offered sequentially (i.e., one at a time for the condition that is most prominent). Treating these conditions separately may overlook their interconnected nature, which may reduce efficacy and increase dropout. Thus, there is a need for an intervention to target both simultaneously, which may be more effective and efficient than treating conditions sequentially. This is a single-arm pilot study to assess the feasibility and acceptability of an integrated treatment for adults with comorbid PTSD and chronic pain. The intervention consists of 12 90-minute virtual psychotherapy sessions scheduled twice per week. The treatment draws from modules in PE and CBT-CP including psychoeducation, exposure to feared/avoided situations and activities, processing of exposures, behavioral activation, breathing and relaxation techniques, sleep hygiene, symptom monitoring, and structured homework assignments. Baseline and post-treatment assessments will be conducted.
Key Dates
- Start date
- Dec 8, 2025
- Status verified
- Dec 2025
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Integrated PTSD and Chronic Pain TreatmentIntegrated treatment combining modules from Prolonged Exposure Therapy with Cognitive Behavioral Therapy for Chronic Pain
Primary Outcome Measure
Feasibility Indicator: Number of Participants Screened [ Time Frame: Baseline ]
Central Contacts
- Mariel Emrich, MS212-821-0783
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Weill Cornell Medicine | New York | New York | 10065 | JoAnn Difede, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Patient Retrospective Outcomes (PRO)Recruiting · Boston Scientific Corporation · Lake Havasu City, Arizona
- Post-Traumatic Stress Disorder Focused Psychodynamic PsychotherapyRecruiting · Montefiore Medical Center · New York, New York
- A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military PersonnelRecruiting · Weill Medical College of Cornell University · New York, New York
- Long-Term Real-World Outcomes Study on Patients Implanted With a NeurostimulatorRecruiting · Abbott Medical Devices · Phoenix, Arizona